# Spartan Micro, Inc.

- Location (FDA's records): Fremont, CA
- FDA decisions: 4 (2018–2022): 4 510(k) clearances
- Names in FDA's records: Spartan Micro, Inc. (3); Spartan Micro (1)
- Product codes: HCG (1), DQY (1), DQX (1), QJP (1)
- 510(k) review time since 2016: median 77 days, against 156 for FDA's reviews in the same codes and years (3 of 4 faster)
- Predicates its devices cite: 4 (0 its own); citations of its devices by later devices: 0 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Micro Therapeutics, Inc. d/b/a ev3 Neurovascular: 2 (https://510kreport.com/company/micro-therapeutics-d-b-a-ev3-neurovascular)
- Boston Scientific, Target: 1 (https://510kreport.com/company/boston-scientific-target)
- Cathera, Inc.: 1 (https://510kreport.com/company/cathera)

## Recent decisions
- K220716: Spartan SC 069 (May 5, 2022)
- K220075: Spartan Center Wire (Apr 19, 2022)
- K213451: Spartan MC 0165 (Nov 22, 2021)
- K180653: Spartan eCoil System (Dec 4, 2018)

Source page: https://510kreport.com/company/spartan-micro